BrainCo赋思头环
Search documents
强脑科技拟赴港IPO 脑机接口商业化前景如何?
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-26 08:23
Group 1 - The core viewpoint of the articles highlights the growing interest and investment in the brain-computer interface (BCI) sector, with companies like BrainCo preparing for IPOs amid a favorable market environment [1][8] - BrainCo, established in 2015, focuses on non-invasive BCI technology and has recently completed a financing round of approximately 2 billion RMB, achieving a post-investment valuation of over 1.3 billion USD [1] - The BCI market is projected to grow significantly, with estimates suggesting a global market size of approximately 2.6 billion USD in 2024, increasing to 2.9 billion USD in 2025 and further to 3.3 billion USD in 2026 [9] Group 2 - BCIs are primarily expected to impact the medical field, particularly for individuals with neurological impairments, aiming to restore or replace certain neural functions [2] - The BCI technology is categorized into invasive, semi-invasive, and non-invasive types, with non-invasive systems being more widely accepted due to their safety [3] - Companies like Neuralink are leading the invasive BCI path, while BrainCo focuses on non-invasive applications in rehabilitation and health management [3][4] Group 3 - The regulatory landscape for BCI products is becoming clearer, with the National Healthcare Security Administration introducing specific fees for non-invasive BCI adaptations to enhance accessibility [6] - The industry is witnessing a significant increase in R&D investment, with an average R&D expense ratio of about 18% among BCI-related companies [12] - The number of domestic BCI companies in China has surpassed 200, with expectations for the industry scale to reach tens of billions of RMB by 2026 [12] Group 4 - Ethical and regulatory challenges remain a concern in the application of BCI technology, particularly regarding data privacy and the potential for misuse in educational settings [7] - The market for BCI is experiencing a phase of industrial expansion, with a notable increase in financing activities, indicating a robust interest in clinical advancements [12] - Policy support is crucial for the BCI sector, with government initiatives aimed at fostering innovation and establishing a competitive industry ecosystem by 2030 [13][14]